Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-005729

Chief Development Officer acquired 38,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 1 in the form +38,500 91,531 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 2 in the form Stock Option (Right to Buy) +77,000 77,000 D
Loading xslF345X03/doc4.xml…